Study of E7070 Combined With Capecitabine to Determine Efficacy and Recommended Dose of Combination in Patients With Metastatic Colorectal Cancer
Phase 2
Completed
- Conditions
- First Posted Date
- 2005-09-14
- Last Posted Date
- 2014-06-27
- Lead Sponsor
- Eisai Limited
- Target Recruit Count
- 46
- Registration Number
- NCT00165854
- Locations
- 🇫🇷
Institut Curie, Paris, France
🇳🇱Netherlands Cancer Institute, Amsterdam, Netherlands
🇩🇪Universitätsklinikum der GHS-Essen, Essen, Germany
A Randomized, Open, Parallel, Optimal Injection Rate-Finding Study for E7337 in Dynamic CT of the Liver in Patients With Liver Disease
Phase 2
Completed
- Conditions
- First Posted Date
- 2005-09-14
- Last Posted Date
- 2010-01-29
- Lead Sponsor
- Eisai Limited
- Registration Number
- NCT00165620
A Comparative Study of KES524 in Patients With Obesity Disease
Phase 3
Completed
- Conditions
- First Posted Date
- 2005-09-14
- Last Posted Date
- 2010-01-29
- Lead Sponsor
- Eisai Limited
- Registration Number
- NCT00165685
A Multi-Center, Randomized, Double-Blind, Parallel Group Study With 3 Groups Receiving Placebo, 5 mg of E2020 and 10 mg of E2020
Phase 2
Completed
- Conditions
- First Posted Date
- 2005-09-14
- Last Posted Date
- 2010-01-29
- Lead Sponsor
- Eisai Limited
- Registration Number
- NCT00165659
A Phase II/III Clinical Study on Inhibitory Effects of E0167 on Recurrence of Hepatocellular Carcinoma
- First Posted Date
- 2005-09-14
- Last Posted Date
- 2008-12-09
- Lead Sponsor
- Eisai Limited
- Target Recruit Count
- 540
- Registration Number
- NCT00165633
The Efficacy, Safety, And Tolerability Of Donepezil HCl (E2020) In Patients With CADASIL Who Have Cognitive Impairment
Phase 2
Completed
- Conditions
- First Posted Date
- 2005-02-18
- Last Posted Date
- 2015-11-03
- Lead Sponsor
- Eisai Limited
- Target Recruit Count
- 165
- Registration Number
- NCT00103948
- Locations
- 🇺🇸
New York University School of Medicine, New York, New York, United States
🇺🇸Jose Biller, M.D., Maywood, Illinois, United States
© Copyright 2024. All Rights Reserved by MedPath